Evaluation of Safety and Tolerability of ATB-320 in Participants With Progressive or Metastatic Solid Tumors
Clinical trial NCT06933524 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT06933524
- Sponsor
- Autotelicbio
- Status
- NOT_YET_RECRUITING
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2025-12-01
- Primary completion
- 2028-12-01
- Enrollment
- 24
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.